prasugrel

The medicine is used to reduce the risk of heart attack, stroke, or death in patients who have undergone coronary artery procedures and suffer from myocardial infarction or unstable angina. It inhibits platelet aggregation, which prevents the formation of dangerous blood clots.

Form: tablets, film-coated

ATC: B01AC22

Manufacturer: Gedeon Richter Romania S.A.

Sigrada is used to reduce the risk of a recurrent myocardial infarction (heart attack), stroke, or death in patients who have had a heart attack or unstable angina and have undergone arterial revascularization (e.g., stent placement). The medicine inhibits platelet aggregation, which prevents the formation of dangerous blood clots.

Form: tablets, film-coated

ATC: B01AC22

Manufacturer: Krka, d.d., Novo mesto

Sigrada is used to reduce the risk of a recurrent myocardial infarction (heart attack), stroke, or death in patients who have had a heart attack or unstable angina and have undergone an arterial revascularization procedure (e.g., stent placement). It inhibits platelet aggregation, which prevents the formation of dangerous blood clots.

Form: tablets, film-coated

ATC: B01AC22

Manufacturer: Krka, d.d., Novo mesto

The medicine is used to reduce the risk of a recurrent myocardial infarction (heart attack), stroke, or death in people who have had a heart attack or unstable angina and have undergone arterial revascularization (e.g., stent placement). It inhibits platelet aggregation, which prevents the formation of dangerous blood clots.

Form: tablets, film-coated

ATC: B01AC22

Manufacturer: S.C. Zentiva S.A., Zentiva, k.s.

The medicine is used to reduce the risk of recurrent myocardial infarction, stroke, or death in individuals who have had a heart attack or unstable angina and have undergone arterial revascularization (e.g., stent placement). It inhibits platelet aggregation, which prevents the formation of dangerous blood clots.

Form: tablets, film-coated

ATC: B01AC22

Manufacturer: S.C. Zentiva S.A., Zentiva, k.s.